Evidence map›Paper›PMID 30728185›Full record

ArticleDiabetes2019

Monosodium Urate Contributes to Retinal Inflammation and Progression of Diabetic Retinopathy.

Menaka C Thounaojam, Annalisa Montemari, Folami L Powell, Prerana Malla, Diana R Gutsaeva, Alessandra Bachettoni, Guido Ripandelli, Andrea Repossi, Amany Tawfik, Pamela M Martin and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Menaka C ThounaojamDepartment of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA.
Annalisa MontemariIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Pediatrico "Bambino Gesù," Rome, Italy.
Folami L PowellDepartment of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA.
Prerana MallaDepartment of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA.
Diana R GutsaevaDepartment of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA.
Alessandra BachettoniDepartment of Experimental Medicine and Pathology, University of Rome "LaSapienza," Rome, Italy.
Guido RipandelliIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G.B. Bietti, Rome, Italy.
Andrea RepossiUnità Operativa Complessa (UOC) Vitreoretina Ospedale San Carlo di Nancy, Rome, Italy.
Amany TawfikDepartment of Oral Biology, Dental College of Georgia, Augusta University, Augusta, GA.
Pamela M MartinDepartment of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA.
Francesco FacchianoDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Manuela BartoliDepartment of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA mbartoli@augusta.edu.ORCID 0000-0003-1991-6775
Augusta University · USBambino Gesù Children's Hospital · ITFondazione G.B. Bietti · ITIstituto Superiore di Sanità · ITOspedale San Carlo · ITSapienza University of Rome · IT

Funding

Molecular basis of inflammation in retina, and novel strategies for limiting itR01EY022704 · NEI · AUGUSTA UNIVERSITY · PI MARTIN, PAMELA M · 2014 to 2018
$2.2M
Regulation of endogenous antioxidant systems in diabetic retinopathyR01EY022416 · NEI · AUGUSTA UNIVERSITY · PI BARTOLI, MANUELA · 2013 to 2017
$1.9M
Homocysteine's role in Age-Related Macular DegenerationR01EY029751 · NEI · OAKLAND UNIVERSITY · PI TAWFIK, AMANY M · 2019 to 2023
$1.8M
Uric Acid and Diabetic RetinopathyR01EY028714 · NEI · AUGUSTA UNIVERSITY · PI BARTOLI, MANUELA · 2018 to 2021
$1.5M
NEI NIH HHS R01 EY022416NEI NIH HHS R01 EY022704NEI NIH HHS R01 EY028714NEI NIH HHS R01 EY029751
6 · The paper itself

Abstract

We have investigated the contributing role of monosodium urate (MSU) to the pathological processes associated with the induction of diabetic retinopathy (DR). In human postmortem retinas and vitreous from donors with DR, we have found a significant increase in MSU levels that correlated with the presence of inflammatory markers and enhanced expression of xanthine oxidase. The same elevation in MSU levels was also detected in serum and vitreous of streptozotocin-induced diabetic rats (STZ-rats) analyzed at 8 weeks of hyperglycemia. Furthermore, treatments of STZ-rats with the hypouricemic drugs allopurinol (50 mg/kg) and benzbromarone (10 mg/kg) given every other day resulted in a significant decrease of retinal and plasma levels of inflammatory cytokines and adhesion factors, a marked reduction of hyperglycemia-induced retinal leukostasis, and restoration of retinal blood-barrier function. These results were associated with effects of the hypouricemic drugs on downregulating diabetes-induced levels of oxidative stress markers as well as expression of components of the NOD-like receptor family pyrin domain-containing protein 3 (NLRP3) inflammasome such as NLRP3, Toll-like receptor 4, and interleukin-1β. The outcomes of these studies support a contributing role of MSU in diabetes-induced retinal inflammation and suggest that asymptomatic hyperuricemia should be considered as a risk factor for DR induction and progression.

Indexed as

AllopurinolAnimalsBenzbromaroneDiabetes Mellitus, ExperimentalDiabetic RetinopathyHumansHyperuricemiaInflammationMaleNLR Family, Pyrin Domain-Containing 3 ProteinRatsRetinaRisk FactorsUric AcidVitreous BodyXanthine OxidaseAllopurinolBenzbromaroneNLR Family, Pyrin Domain-Containing 3 ProteinUric AcidXanthine Oxidase

Identifiers

PMID30728185
PMCPMC6477903
OpenAlexW2911525349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.